RESEARCH PAPER
Selected metalloproteinases and their inhibitors in prediction of nifedypine tocolysis effectiveness
 
More details
Hide details
1
Zakład Fizjopatologii, Instytut Medycyny Wsi, Lublin
2
Oddział Położniczy i Trakt Porodowy, Samodzielny Publiczny Szpital Wojewódzki im. Jana Bożego, Lublin
3
Samodzielna Pracownia Badań Izobolograficznych, Instytut Medycyny Wsi w Lublinie
4
Klinika Dermatologii, Wenerologii i Dermatologii Dziecięcej, Uniwersytet Medyczny, Lublin
 
Med Og Nauk Zdr. 2015;21(1):1–3
KEYWORDS
ABSTRACT
Introduction:
Matrix metalloproteinases and their inhibitors play an important role in pregnancy, childbirth and postpartum. This system allows inflammatory response cells migration to damaged tissues, release cytokines and cytokine receptors. Preterm cervical ripening is an inflammatory process, with cytokines as important mediators. Objective. The purpose of this study was to evaluate the relationship between metalloproteinases MMP -2 and MMP -9 and their inhibitors TIMP -1 and TIMP -2 in patients with preterm labour in the prediction of nifedypine tocolysis efficacy.

Material and Methods:
The study included 21 women with preterm labour and 35 healthy pregnant women below 37 weeks of gestation. The patients were divided into three groups: the first group consisted of patients with preterm labour with ineffective tocolysis, the second group of women with preterm labour responded to tocolysis, the third group consisted of healthy pregnant women. The level of serum MMP -2, MMP – 9 and TIMP1 and TIMP2 was assessed using the ELISA kit.

Results:
The concentration of MMP -2 in preterm labour patients was not significantly different compared to the control group. In women with a preterm labour level of MMP -9 was higher than in healthy pregnant women. The concentration of TIMP -1 and TIMP -2 in sera of pregnant women with preterm delivery was higher compared to the control group. It was found that in women with preterm labour with ineffective tocolysis, the level of TIMP -1 was higher, while the level of TIMP -2 was significantly lower compared to pregnant women with ineffective tocolysis.

Conclusions:
Ineffective tocolysis may be due to the stage of inflammation at the start of therapy. Activation of the proteolytic activity of gelatinase / inhibitors system may indicate an active process leading to cervix shortening and dilating in preterm labour, and increased activity of metalloproteinase inhibitors is probably a defence mechanism, as noted.

 
REFERENCES (20)
1.
Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol. 1988; 31: 554–584.
 
2.
Taylor D, Kenyon S, Tarnow-Mordi W. Infection and preterm labour. Br J Obstet Gynaecol. 1997; 104: 1338–1340.
 
3.
Foulon W, Van Liedekerke D, Demanet C, et al. Markers of infection and their relationship to preterm delivery. Am J Perinatol. 1995; 12: 208–211.
 
4.
Mitchel MD, Dudley DJ, Edwin SS. Interleukin-6 stimulates prostaglan¬din production by human amnion and decidual cells. Eur J Pharmacol. 1991; 192: 189–191.
 
5.
Brown NL, Alvi SA, Elder MG, et al. A spontaneous induction of fetal membrane prostaglandin production precedes clinical labor. J Endocrinol. 1998; 157: R1-R6.
 
6.
Phillipe M, Saunders T, Basa A. Intracellular mechanisms underlying prostaglandin F2a-stimulated phasic myometrial contractions. Am J Physiol. 1999; 273: 665–673.
 
7.
Palm M, Axelsson O, Wernroth L, Basu S. F(2)-Isoprostanes, tocopherols and normal pregnancy. Free Radic Res. 2009; 22: 1–7.
 
8.
Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999; 274: 21491–21494.
 
9.
Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem. 1997; 378: 151–160.
 
10.
Roberts LJ, Morrow JD. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med. 2000; 28: 505–513.
 
11.
Montagnana M, Lippi G, Albiero A, et al. Evaluation of metallopro¬teinases 2 and 9 and their inhibitors in physiologic and pre-eclamptic pregnancy. J Clin Lab Anal. 2009; 23: 88–92.
 
12.
Tu FF, Goldenberg RL, Tamura T, et al. Prenatal plasma matrix me¬talloproteinase-9 levels to predict spontaneous preterm birth. Obstet Gynecol. 1998; 92: 446–449.
 
13.
Yoon BH, Oh SY, Romero R, et al. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol. 2001; 185: 1162–1167.
 
14.
Zucker S, Hymowitz M, Conner C, et al. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann N Y Acad Sci. 1999; 878: 212–227.
 
15.
Wahl LM, Corcoran ML. Regulation of monocyte/macrophage metalloproteinase production by cytokines. J Periodontol. 1993; 64: 467–473.
 
16.
Foulon W, Van Liedekerke D, Demanet C, et al. Markers of infection and their relationship to preterm delivery. Am J Perinatol. 1995; 12: 208–212.
 
17.
Greig PC, Murtha AP, Jimmerson CJ, et al. Maternal serum interleukin-6 during pregnancy and during term and pre-term labor. Obstet Gynecol. 1997; 90: 465–469.
 
18.
Kelly RW. Inflammatory mediators and parturition. Rev Reprod. 1996; 1: 89–96.
 
19.
Mitchel MD, Dudley DJ, Edwin SS. Interleukin-6 stimulates prostaglandin production by human amnion and decidual cells. Eur J Pharmacol. 1991; 192: 189–192.
 
20.
Maymon E, Romero R, Pacora P, et al. A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection. J Perinat Med. 2001; 29: 308–316.
 
eISSN:2084-4905
ISSN:2083-4543